AstraZeneca pays $600m for Chinese lung cancer drug rights
AstraZeneca pays $600m for Chinese lung cancer drug rights
Similar Posts
Billionaires are loading up on these superior stocks. Why it pays to follow their money.
The second quarter was a six-year best for U.S. stocks — here are the three sectors poised to lead the next leg higher.
Changes to collateral eligibility in the Sterling Monetary Framework – Market Notice 11 June 2026
Market Notice This Market Notice covers changes to the Bank’s collateral eligibility framework for the Sterling Monetary Framework (SMF). This is in the context of supporting the transition to a repo-led, demand-driven operating framework for supplying central bank reserves and is in part motivated by feedback received in response to the related Discussion Paper. The changes in…
Tax Triangle Strategy: How to Invest an Inheritance
What happens when a sudden $850,000 inheritance turns into eight different account balances, three rental properties, and one very big decision about your future? When grief, real estate, and a six-figure windfall collide all at once, the fastest way to make an expensive mistake is to rush into “doing something” with the money. Joe and…
Can I Retire? What $862K Really Means at 50
What happens when you look at a $862,000 portfolio and realize early retirement might actually be out of reach? When a mountain of ticker symbols, account balances, and unexpected life updates come hitting you all at once, your money plan can quickly start to look like a complete mess. Joe and I break down how to…
Things the Middle Class Should Cut From Budgets If Inflation Stays High
Liubomyr Vorona / iStock.com Commitment to Our Readers GOBankingRates’ editorial team is committed to bringing you unbiased reviews and information. We use data-driven methodologies to evaluate financial products and services – our reviews and ratings are not influenced by advertisers. You can read more about our editorial guidelines and our products and services review methodology….
